Prestin as an Otologic Biomarker of Cisplatin Ototoxicity in a Guinea Pig Model
- 21 November 2017
- journal article
- research article
- Published by Wiley in Otolaryngology -- Head and Neck Surgery
- Vol. 158 (3), 541-546
- https://doi.org/10.1177/0194599817742093
Abstract
To evaluate (1) whether changes in serum prestin aid in early detection of cisplatin ototoxicity, (2) the role of diltiazem as an otoprotectant, and (3) whether prestin levels are sensitive to effects of diltiazem. Experimental animal study. Translational research laboratory. Twenty female guinea pigs. Two groups of 10 guinea pigs were used. The relationship between serum prestin levels and auditory brainstem response (ABR) thresholds was compared between the groups. All animals had baseline blood draws and ABR thresholds recorded prior to cisplatin administration. Intraperitoneal cisplatin bolus (8 mg/kg) was administered followed by 5 consecutive days of intratympanic (IT) diltiazem (2 mg/kg) or sham IT-saline injection. Serum prestin levels and ABR thresholds were measured at days 1, 2, 3, 7, and 14 postcisplatin. In sham, IT-saline–treated animals, mean prestin levels were elevated above baseline on days 1 to 7. The prestin levels were significantly elevated from baseline on day 1 (P < .001), while significant ABR threshold elevations did not occur until day 2 (P = .028) for click-evoked ABRs and day 3 (P = .041) for tones. In diltiazem-treated animals, prestin levels were not elevated above baseline but ABR thresholds were elevated on days 1 to 3. However, the thresholds returned toward baseline on days 7 and 14. Changes in serum prestin levels were detectable prior to shifts in ABR thresholds in a guinea pig cisplatin ototoxicity model. These changes did not occur in diltiazem-treated animals. Prestin may serve as a biomarker of cochlear injury that is sensitive to therapeutic interventions in cisplatin ototoxicity.Keywords
This publication has 21 references indexed in Scilit:
- Outer Hair Cell Molecular Protein, Prestin, as a Serum Biomarker for Hearing LossOtology & Neurotology, 2016
- Preliminary Report on the Investigation of the Association Between BPPV and Osteoporosis Using BiomarkersOtology & Neurotology, 2015
- Prestin as a biochemical marker for early detection of acquired sensorineural hearing lossMedical Hypotheses, 2015
- Inner Ear Protein as a Biomarker in Circulation?Otolaryngology -- Head and Neck Surgery, 2014
- Mechanisms of cisplatin ototoxicity: theoretical reviewThe Journal of Laryngology & Otology, 2013
- Reactive oxygen species in apoptosis induced by cisplatin: review of physiopathological mechanisms in animal modelsEuropean Archives of Oto-Rhino-Laryngology, 2012
- The anticancer drug cisplatin induces an intrinsic apoptotic pathway inside the inner earBritish Journal of Pharmacology, 2007
- Mechanisms of cisplatin-induced ototoxicity and preventionHearing Research, 2007
- Ototoxicity: therapeutic opportunitiesDrug Discovery Today, 2005
- Mechanisms of Cell Death in the Injured Auditory System: Otoprotective StrategiesAudiology and Neurotology, 2002